Status:
UNKNOWN
Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma
Lead Sponsor:
He Xia
Conditions:
Nasopharyngeal Carcinoma
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
This is a randomized Phase III study to evaluate efficancy of weekly cisplatin or nedaplatin concurrent with Intensity-modulated radiation therapy in Nasopharyngeal Carcinoma (NPC).
Eligibility Criteria
Inclusion
- Pathologically confirmed untreated NPC patients
- T1-2N1-3M0 or T3-4NxM0
- 18-70 years old
- with MRI examinations
- ECOG ≤ 2
- With written consent
Exclusion
- With a second cancer
- Pregnancy
- With other severe diseases (blood,liver ,kidney or heart diseases)
- Could not be staged properly
- Without written consent
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT02301208
Start Date
December 1 2014
Last Update
December 8 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.